Levin Capital Strategies »

Crispr Therapeutics shares owned by Levin Capital Strategies

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Levin Capital Strategies from 13F filings

Historical chart of Levin Capital Strategies investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Levin Capital Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Levin Capital Strategies

Quarter filed Position value Share count Share price at filing
2024-09-30 $514k 11k 46.98
2024-06-30 $375k 6.9k 54.01